PMA P170030S018

Device
ORSIRO Sirolimus Eluting Coronary Stent System
Applicant
Biotronik AG
PMA number
P170030
Supplement
S018
Product code
NIQ
Decision date
2021-07-28
Generic name
Coronary drug-eluting stent
Approval order statement
Changes to the stability study parameters and the introduction of a leak test method for packaging integrity testing.

Current openFDA PMA Record#

Device
ORSIRO Sirolimus Eluting Coronary Stent System
Applicant
Biotronik AG
PMA number
P170030
Supplement
S018
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2021-07-28
Decision code
OK30
Date received
2021-07-02
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Changes to the stability study parameters and the introduction of a leak test method for packaging integrity testing.